|
- Current Students
|
|
Student Resources
|
|
Student Publications
|
|
Blanke, Kristina
|
|
Boley, Patricia
|
|
Bolterstein, Elyse
|
|
Booth, Clarissa
|
|
Brody, Matthew
|
|
Bultman, JoAnna
|
|
Burns, Felipe
|
|
Desotelle, Josh
|
|
Ding, Lina
|
|
Elmergreen, Tammy
|
|
Hutchinson, John
|
|
Irving, Amy
|
|
Irving, Roy
|
|
Johnson, Brian
|
|
Johnson, Delinda
|
|
Johnson, Shaina
|
|
Jung-Hynes, Brittney
|
|
Kumar, Kartik
|
|
Lee, Sung-Kyoung
|
|
Lorch, Jeff
|
|
Mehta, Vatsal
|
|
Novick, Rachel
|
|
Park, Heesoo
|
|
Pham, Ly
|
|
Poenitzsch, Ashley
|
|
Rhoads, Keelia
|
|
Rufer, Echoleah
|
|
Sand, Jordan
|
|
Schmit, Travis
|
|
Shan, Weihua
|
|
Shanle, Erin
|
|
Shetty, Ameesha
|
|
Syed, Deeba
|
|
Tarapore, Rohinton
|
|
Velasco, Javier
|
|
Wiecinski, Paige
|
|
Wong, Letitia
|
|
Yang, Sarah
|
|
Yu, Min
|
|
Zhao, Yun
|
|
Calkins, Marcus
|
|
|
|
|
|
Park, Heesoo
Heesoo Park - Email
PhD Candidate - Started Fall 2008
Seoul, Korea
Lab of Jaehyuk Yu, PhD
Undergraduate & Graduate Work
2006 - Masters in Life Sciences with Handong Global University; Kyungbak, Korea
2004 - BS in Life and Food Science from Handong Global University; Kyungbak, Korea
Work Experienc
2006-07 - CystalGenmics, Inc Seoul, Korea
2007-08 - The Institute for Biomedical Research - Handong University
Interests
Why I Joined METC
Publications- Park HS, Yoon YM, Jung SJ, Kim CM, Kim JM, Kwak JH. CG400462, a new bacterial enoyl-acyl carrier protein reductase (FabI) Inhibitor. Int J Antimicrob Agents Accepted: 2007 Nov:30(5):446-451
- Park HS, Yoon YM, Jung SJ, Kim CM, Kim JM, Kwak JH. Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. J Antimicrob Chemother. 2007 Sep;60:568-574
- Park HS, Kim HJ, Seol MJ, Choi DR, Choi EC, Kwak JH. In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone. Antimicrob Agents Chemother. 2006 Jun;50(6):2261-2264.
- Kim HJ, Seol MJ, Park HS, Choi DR, Seong SK, Shin HK, Kwak JH. Antimicrobial activity of DW-224a, a new fluoroquinolone, against Streptococcus pneumoniae. J Antimicrob Chemother. 2006 Jun;57(6):1256-8.
Posters- M. J. Seol, H. J. Kim, H. S. Park, D. R. Choi, Y. Jung, and J. H. Kwak In vitro and In vivo Antibacterial Activities of the New Fluoroquinolone, DW-224a. 43th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2003.
- M. J. Seol, H. J. Kim, H. S. Park, D. R. Choi, and J. H. Kwak. Characterization of mutations in DNA gyrase and topoisomerase ‡W involved in resistant mutants to DW-286a, a novel quinolone antibiotic, in Streptococcus pneumoniae. Proceedings of the Convention of the Pharmaceutical Society of Korea. The pharmaceutical society of Korea. 2003
- H. J. Kim, M. J. Seol, H. S. Park, J. K Lee, S. Y. Choi and J. H. Kwak. Screening of new antibiotics inhibiting bacterial peptide deformylase. Proceedings of the Convention of the Pharmaceutical Society of Korea. The pharmaceutical society of Korea. 2003
- M. J. Seol, H. J. Kim, H. S. Park, D. R. Choi, Y. Jung, and J. H. Kwak. Bactericidal Activities of DW-224a, a New Fluoroquinolone. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2004.
- H. S. Park, Y. M. Yoon, S. J. Jung, D. R. Choi, and J. H. Kwak. In vitro and In vivo antibacterial activity of DW-224a against susceptible and resistant Gram positive organism. 5th International Symposium on Antimicrobial Agents and Resistance Asian-Pacific Research Foundation for Infectious Diseases, 2005
- H. S. Park, S. J. Jung, Y. M. Yoon, D. R. Choi, and J. H. Kwak. DNA Gyrase and Topoisomerase ‡W Are Dual Targets of DW-224a in Streptococcus pneumoniae Proceedings of the Convention of the Pharmaceutical Society of Korea. The pharmaceutical society of Korea. 2005
- H. S. Park, S. J. Jung, D. R. Choi, and J. H. Kwak. In Vitro and In Vivo Efficacy of a New Fluoronaphthyridone, DW-224a, against Streptococcus pneumoniae. Proceedings of the Convention of the Pharmaceutical Society of Korea. The pharmaceutical society of Korea. 2005
- C. M. Kim, J. H. Kwak, Y. S. Kim, H. J. Yoon, H. S. Park, J. M. Kim, Y. M. Song, Y. E. Kim, Y. L Hyun, S. G. Ro, T. G. Lee and J. M Cho. Antimicrobial activity of CG400549 tested against clinically isolated MRSA strain. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2005.
- C. M. Kim, J. M. Kim, Y. M. Song, C. S. Lee, H. S. Park, S. K. Kang, J. H. Kwak, Y. S. Huh. D. G. Shin, S. G. Ro, T. G. Lee and J. M Cho. CG400549, a novel FabI inhibitor with potent in vitro activity. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2005.
- C. M. Kim, Y. S. Kim, J. H. Kwak, H. J. Yoon, H. S. Park, J. M. Kim, S. G. Ro, T. G. Lee and J. M Cho. Time-kill kinetics, Post-antibiotic effect and mutation frequency of CG400549. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2005
- H. S. Park, C. M. Kim, Y M. Yoon, S. J. Jung. I. N. R. Yun, J. M. Kim, S. G. Ro, J. M. Cho J. H. Kwak. In vitro and in vivo activity of CG4000549, a novel FabI inhibitor, against QRSA. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2006
- H. S. Park, C. M. Kim, Y. M. Yoon, S. J. Jung, I. N. R. Yun, J. M. Kim, S. G. Ro, J. H. Kwak. Antistaphylococcal Activities of CG400462, Novel FabI Inhibitors. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2006
- H. S. Park, Y. M. Yoon, S. J. Jung. D. R. Choi, J. M. Ryo. J. H. Kwak. DNA gyras and topoisomerase ‡W are dual targets of DW-224a, a new fluoroquinolone, in Streptococcus pneumoniae. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2006
- S. J. Jung, I. N. R. Yun, H. S. Park, S. H. Woo, J. H. Kwak. In Vitro Activity of LCB01-0062, Novel Oxazolidinones against Gram Positive Cocci. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology 2007.
|
|